Surgify Medical appoints Alan Raffensperger as Chairman of the Board.

Surgify Medical appoints Alan Raffensperger as Chairman of the Board.

Surgify Medical, the Finnish surgical technology company leading the way for safer bone surgery, is excited to announce the appointment of Alan Raffensperger as Chairman of the Board.

With a proven track record in the healthcare industry, Alan brings a wealth of experience and strategic insights to Surgify Medical.

Alan Raffensperger’s career spans both the MedTech and life science sectors, having held senior leadership and board positions at Amgen, Roche, Pfizer, Sobi, Inceptua Group, and Spago Nanomedical AB in addition to CEO roles within surgery technology and MedTech.

His expertise in business development, commercialization, and corporate strategy will be invaluable as Surgify Medical continues to expand its operations and deliver innovative surgical solutions to surgeons and patients worldwide.

Please join us in welcoming Alan Raffensperger to the Surgify Medical team.

‍